Did you mean aromatase inhibitor?
Displaying drugs 2276 - 2300 of 2435 in total
Hydracarbazine
Hydracarbazine is a pyridazine that has found use as an antihypertensive agent It was once marketed in France under the tradename Normatensyl.
Experimental
Matched Categories: … Monoamine Oxidase Inhibitors …
Octamoxin
Octamoxin, also known as 2-octylhydrazine, is both an irreversible and nonselective monoamine oxidase enzyme inhibitor (MAOI) of the hydrazine chemical class. This drug was used in the past as an antidepressant agent in the 1960s, however, has since been discontinued.
Withdrawn
Matched Categories: … Monoamine Oxidase Inhibitors …
TAK-901
TAK-901 has been used in trials studying the treatment of Lymphoma, Myelofibrosis, Multiple Myeloma, Myeloid Metaplasia, and Advanced Solid Tumors, among others.
Investigational
Matched Categories: … Protein Kinase Inhibitors …
Spartalizumab
Spartalizumab is under investigation in clinical trial NCT02605967 (Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma).
Investigational
Matched Categories: … Immune Checkpoint Inhibitors …
Opipramol
Opipramol has been used in trials studying the treatment of Dementia, Depression, Schizophrenia, Anxiety Disorders, and Psychosomatic Disorders.
Investigational
Matched Categories: … Neurotransmitter Uptake Inhibitors ... Non-Selective Monoamine Reuptake Inhibitors …
Faldaprevir
Faldaprevir has been investigated for the treatment of Chronic Hepatitis C.
Investigational
Matched Categories: … Enzyme Inhibitors ... Protease Inhibitors …
Benzquinamide
Benzquinamide is a discontinued antiemetic compound with antihistaminic, mild anticholinergic, and sedative properties. The mechanism of action is not known, but presumably benzquinamide works via antagonism of muscarinic acetycholine receptors and histamine H1 receptors.
Withdrawn
Matched Categories: … P-glycoprotein inhibitors …
Otenabant
Otenabant has been investigated for the treatment of Obesity.
Investigational
Matched Categories: … Receptor, Cannabinoid, CB1, antagonists & inhibitors …
ABT-384
ABT-384 has been used in trials studying the treatment of Alzheimer's Disease.
Investigational
Matched Categories: … 11-beta-Hydroxysteroid Dehydrogenase Type 1, antagonists & inhibitors …
Moexiprilat
The active metabolite of the prodrug Moexipril.
Experimental
Matched Categories: … Angiotensin-Converting Enzyme Inhibitors …
Levilimab
Levilimab is under investigation in clinical trial NCT04227366 (Study of the Efficacy and Safety of BCD-089 in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis).
Investigational
Matched Categories: … Interleukin Inhibitors …
Reposal
Reposal is a barbiturate derivative invented in the 1960s in Denmark that has sedative, hypnotic and anticonvulsant properties. It was used primarily in the treatment of insomnia.
Experimental
Matched Categories: … Enzyme Inhibitors …
Balanol
Experimental
Matched Categories: … Cyclic AMP-Dependent Protein Kinases, antagonists & inhibitors …
Acifluorfen
Acifluorfen is a protoporphyrinogen oxidase inhibitor.
Experimental
Matched Categories: … Enzyme Inhibitors …
Binetrakin
Binetrakin has been used in trials studying the treatment of HIV Infections, Sarcoma, Kaposi, Non-Hodgkin's Lymphoma (NHL), Myelodysplastic Syndrome (MDS), and Leukemia, Acute Myelogenous (AML), among others.
Investigational
Matched Categories: … Interleukin-4, antagonists & inhibitors …
Defactinib
Defactinib has been investigated for the treatment of Malignant Pleural Mesothelioma.
Investigational
Matched Categories: … Focal Adhesion Kinase 1, antagonists & inhibitors …
Surufatinib
Surufatinib is under investigation in clinical trial NCT02588170 (Phase III Study of Surufatinib in Treating Advanced Extrapancreatic Neuroendocrine Tumors).
Investigational
Matched Categories: … Protein Kinase Inhibitors …
Seratrodast
Seratrodast (INN) is a thromboxane receptor antagonist used primarily in the treatment of asthma.
Experimental
Matched Categories: … Cytochrome P-450 CYP2A6 Inhibitors ... Cytochrome P-450 Enzyme Inhibitors ... Cytochrome P-450 CYP2A6 Inhibitors (strength unknown) …
Idasanutlin
Idasanutlin has been used in trials studying the treatment of Neoplasms, Non-Hodgkin's Lymphoma, Leukemia, Myeloid, Acute, Recurrent Plasma Cell Myeloma, and Neoplasms, Leukemia, Acute Myeloid Leukemia.
Investigational
Matched Categories: … Proto-Oncogene Proteins c-mdm2, antagonists & inhibitors …
BLZ-945
Investigational
Matched Categories: … Receptor, Macrophage Colony-Stimulating Factor, antagonists & inhibitors …
Picric acid
Used as antiseptic, astringent, and stimulant for epitheliazation.
Experimental
Matched Categories: … Enzyme Inhibitors …
Displaying drugs 2276 - 2300 of 2435 in total